Literature DB >> 10704222

Intrinsic structural disorder of the C-terminal activation domain from the bZIP transcription factor Fos.

K M Campbell1, A R Terrell, P J Laybourn, K J Lumb.   

Abstract

The bZIP proto-oncoprotein c-Fos activates transcription of a wide variety of genes involved in cell growth. The C-terminal activation domain of c-Fos is functionally independent of the remainder of the protein. Fos-AD corresponds to the C-terminal activation domain of human c-Fos (residues 216-380). Fos-AD suppresses (squelches) transcription in vitro, as expected for a functional activation domain lacking a DNA-binding domain. Fos-AD is unstructured and highly mobile, as demonstrated by circular dichroism spectra indicative of unfolded proteins, a lack of (1)H chemical shift dispersion, and negative (1)H-(15)N heteronuclear nuclear Overhauser effects. The hydrodynamic properties of Fos-AD are also consistent with an extended structure. We conclude that the C-terminal domain of human c-Fos is biologically active yet intrinsically disordered. Our results suggest that conformational disorder is an integral aspect of the diverse contributions to transcriptional regulation by c-Fos.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10704222     DOI: 10.1021/bi9923555

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  33 in total

Review 1.  Natively unfolded proteins: a point where biology waits for physics.

Authors:  Vladimir N Uversky
Journal:  Protein Sci       Date:  2002-04       Impact factor: 6.725

2.  Proteomics of Mycoplasma genitalium: identification and characterization of unannotated and atypical proteins in a small model genome.

Authors:  S Balasubramanian; T Schneider; M Gerstein; L Regan
Journal:  Nucleic Acids Res       Date:  2000-08-15       Impact factor: 16.971

Review 3.  Understanding protein non-folding.

Authors:  Vladimir N Uversky; A Keith Dunker
Journal:  Biochim Biophys Acta       Date:  2010-02-01

4.  Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1/2 pathway-mediated phosphorylation of a unique C-terminal destabilizer.

Authors:  Jihane Basbous; Dany Chalbos; Robert Hipskind; Isabelle Jariel-Encontre; Marc Piechaczyk
Journal:  Mol Cell Biol       Date:  2007-03-19       Impact factor: 4.272

5.  Functional anthology of intrinsic disorder. 3. Ligands, post-translational modifications, and diseases associated with intrinsically disordered proteins.

Authors:  Hongbo Xie; Slobodan Vucetic; Lilia M Iakoucheva; Christopher J Oldfield; A Keith Dunker; Zoran Obradovic; Vladimir N Uversky
Journal:  J Proteome Res       Date:  2007-03-29       Impact factor: 4.466

6.  Functional anthology of intrinsic disorder. 1. Biological processes and functions of proteins with long disordered regions.

Authors:  Hongbo Xie; Slobodan Vucetic; Lilia M Iakoucheva; Christopher J Oldfield; A Keith Dunker; Vladimir N Uversky; Zoran Obradovic
Journal:  J Proteome Res       Date:  2007-03-29       Impact factor: 4.466

7.  c-Fos proteasomal degradation is activated by a default mechanism, and its regulation by NAD(P)H:quinone oxidoreductase 1 determines c-Fos serum response kinetics.

Authors:  Julia Adler; Nina Reuven; Chaim Kahana; Yosef Shaul
Journal:  Mol Cell Biol       Date:  2010-05-24       Impact factor: 4.272

Review 8.  Intrinsically disordered proteins and their environment: effects of strong denaturants, temperature, pH, counter ions, membranes, binding partners, osmolytes, and macromolecular crowding.

Authors:  Vladimir N Uversky
Journal:  Protein J       Date:  2009-10       Impact factor: 2.371

Review 9.  The importance of being flexible: the case of basic region leucine zipper transcriptional regulators.

Authors:  Maria Miller
Journal:  Curr Protein Pept Sci       Date:  2009-06       Impact factor: 3.272

10.  An overview of the importance of conformational flexibility in gene regulation by the transcription factors.

Authors:  Shagufta H Khan; Raj Kumar
Journal:  J Biophys       Date:  2010-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.